AAAAAA
Results:
1-19
|
Results: 19
Authors:
Bhana, N
Foster, RH
Olney, R
Plosker, GL
Citation: N. Bhana et al., Olanzapine - An updated review of its use in the management of schizophrenia, DRUGS, 61(1), 2001, pp. 111-161
Authors:
Foster, RH
Citation: Rh. Foster, Ethylene vinyl alcohol copolymer (EVOH) resins, COATINGS TECHNOLOGY HANDBOOK, SECOND EDITION, 2001, pp. 473-477
Authors:
Foster, RH
Plosker, GL
Citation: Rh. Foster et Gl. Plosker, Glipizide - A review of the pharmacoeconomic implications of the extended-release formulation in Type 2 diabetes mellitus, PHARMACOECO, 18(3), 2000, pp. 289-306
Authors:
Holm, KJ
Jarvis, B
Foster, RH
Citation: Kj. Holm et al., Mirtazapine - A pharmacoeconomic review of its use in depression, PHARMACOECO, 17(5), 2000, pp. 515-534
Authors:
Plosker, GL
Foster, RH
Citation: Gl. Plosker et Rh. Foster, Eprosartan - A review of its use in the management of hypertension, DRUGS, 60(1), 2000, pp. 177-201
Authors:
Foster, RH
Markham, A
Citation: Rh. Foster et A. Markham, Levobupivacaine - A review of its pharmacology and use as a local anaesthetic, DRUGS, 59(3), 2000, pp. 551-579
Authors:
Plosker, GL
Foster, RH
Citation: Gl. Plosker et Rh. Foster, Tacrolimus - A further update of its pharmacology and therapeutic use in the management of organ transplantation, DRUGS, 59(2), 2000, pp. 323-389
Authors:
Bardsley-Elliot, A
Noble, S
Foster, RH
Citation: A. Bardsley-elliot et al., Mycophenolate mofetil - A review of its use in the management of solid organ transplantation, BIODRUGS, 12(5), 1999, pp. 363-410
Authors:
Dunn, CJ
Foster, RH
Citation: Cj. Dunn et Rh. Foster, Abciximab - A pharmacoeconomic review of its use in percutaneous coronary revascularisation, PHARMACOECO, 16(6), 1999, pp. 711-741
Authors:
Foster, RH
McClellan, KJ
Citation: Rh. Foster et Kj. Mcclellan, Acamprosate - Pharmacoeconomic implications of therapy, PHARMACOECO, 16(6), 1999, pp. 743-755
Authors:
Foster, RH
Plosker, GL
Citation: Rh. Foster et Gl. Plosker, Donepezil - Pharmacoeconomic implications of therapy, PHARMACOECO, 16(1), 1999, pp. 99-114
Authors:
Foster, RH
Goa, KL
Citation: Rh. Foster et Kl. Goa, Olanzapine - A pharmacoeconomic review of its use in schizophrenia, PHARMACOECO, 15(6), 1999, pp. 611-640
Authors:
Peters, DC
Foster, RH
Citation: Dc. Peters et Rh. Foster, Diclofenac/hyaluronic acid, DRUG AGING, 14(4), 1999, pp. 313-319
Authors:
Foster, RH
Rojas, AM
Citation: Rh. Foster et Am. Rojas, Evidence suggesting that the angiotensin II-sensitive intracellular Ca2+ pool is reloaded from the external space in adrenal glomerulosa cells, GEN PHARM, 32(2), 1999, pp. 171-177
Authors:
Foster, RH
De Reyt, S
Citation: Rh. Foster et S. De Reyt, Re-inventing the call centre with predictive and adaptive execution, BR TEL ENG, 18, 1999, pp. 180-184
Authors:
Onrust, SV
Foster, RH
Citation: Sv. Onrust et Rh. Foster, Rapacuronium bromide - A review of its use in anaesthetic practice, DRUGS, 58(5), 1999, pp. 887-918
Authors:
Balfour, JAB
Foster, RH
Citation: Jab. Balfour et Rh. Foster, Deferiprone - A review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases, DRUGS, 58(3), 1999, pp. 553-578
Authors:
Foster, RH
Noble, S
Citation: Rh. Foster et S. Noble, Bivalent cholera and typhoid vaccine, DRUGS, 58(1), 1999, pp. 91-96
Authors:
Foster, RH
Wiseman, LR
Citation: Rh. Foster et Lr. Wiseman, Abciximab: an updated review of its use in ischaemic heart disease (vol 56, pg 629, 1998), DRUGS, 57(1), 1999, pp. 91-91
Risultati:
1-19
|